Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Endoplasmic reticulum membrane Multi-pass membrane protein |
Domain |
PF06728 GPI transamidase subunit PIG-U |
Function |
Component of the GPI transamidase complex. May be involved in the recognition of either the GPI attachment signal or the lipid portion of GPI. |
Biological Process |
GO:0006497 protein lipidation GO:0006505 GPI anchor metabolic process GO:0006506 GPI anchor biosynthetic process GO:0006643 membrane lipid metabolic process GO:0006644 phospholipid metabolic process GO:0006650 glycerophospholipid metabolic process GO:0006661 phosphatidylinositol biosynthetic process GO:0006664 glycolipid metabolic process GO:0007259 JAK-STAT cascade GO:0008654 phospholipid biosynthetic process GO:0009247 glycolipid biosynthetic process GO:0016255 attachment of GPI anchor to protein GO:0042157 lipoprotein metabolic process GO:0042158 lipoprotein biosynthetic process GO:0045017 glycerolipid biosynthetic process GO:0046425 regulation of JAK-STAT cascade GO:0046467 membrane lipid biosynthetic process GO:0046474 glycerophospholipid biosynthetic process GO:0046486 glycerolipid metabolic process GO:0046488 phosphatidylinositol metabolic process GO:0097696 STAT cascade GO:1903509 liposaccharide metabolic process GO:1904892 regulation of STAT cascade |
Molecular Function |
GO:0003923 GPI-anchor transamidase activity GO:0005543 phospholipid binding GO:0034235 GPI anchor binding GO:0035091 phosphatidylinositol binding GO:0051861 glycolipid binding |
Cellular Component |
GO:0030176 integral component of endoplasmic reticulum membrane GO:0031227 intrinsic component of endoplasmic reticulum membrane GO:0042765 GPI-anchor transamidase complex |
KEGG |
hsa00563 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis hsa01100 Metabolic pathways |
Reactome |
R-HSA-162791: Attachment of GPI anchor to uPAR R-HSA-392499: Metabolism of proteins R-HSA-163125: Post-translational modification R-HSA-597592: Post-translational protein modification |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between PIGU and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of PIGU in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of PIGU in various data sets.
|
Points in the above scatter plot represent the mutation difference of PIGU in various data sets.
|
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of PIGU. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of PIGU. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by PIGU. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of PIGU. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of PIGU expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between PIGU and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | PIGU |
Name | phosphatidylinositol glycan anchor biosynthesis, class U |
Aliases | bA346K17.2; CDC91L1; CDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1; CDC91 cell division cycl ...... |
Chromosomal Location | 20q11.22 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting PIGU collected from DrugBank database. |
There is no record. |